全国首家“无痛医院”落户天津

2017-11-20 邱琳荃、胡颜 每日新报

为了积极落实疼痛管理标准体系,树立全国规范治疗标杆,全国首个“无痛医院”项目在天津医科大学肿瘤医院正式启动。

疼痛是肿瘤患者终究要面对的一个问题,疼痛的处理需要一套行之有效的办法。为了积极落实疼痛管理标准体系,树立全国规范治疗标杆,全国首个“无痛医院”项目在天津医科大学肿瘤医院正式启动。蔚蓝丝带关爱癌痛患者大型公益项目也将天津首家“蔚蓝丝带友好医院”的牌匾授予了肿瘤医院。

“无痛医院”将尽可能消除病人就诊、检查和治疗中的痛苦,肿瘤医院会帮助患者在整个就医过程中实现无痛苦、舒适化、没有心理负担。从前期准备,到科室试点,最后扩展到全院“无痛”。

“我国中晚期癌症疼痛发生率平均约为50%,临终期疼痛的发生比例高达70%—90%。2016年《天津市居民健康状况报告》显示,恶性肿瘤已成为我市人口的第二位死亡原因,单一的‘癌痛规范化治疗示范病房’已不能完全满足癌痛规范化治疗的需求,为此创立‘无痛医院’势在必行。”天津市卫计委医政医管处副处长律扬表示。针对“无痛医院”的创建,肿瘤医院已形成一套完整的、系统化的疼痛管理规范,其中包括:完善阿片类药物的管理体系,建立全院疼痛筛查与疼痛会诊转诊制度,完善疼痛培训与质控以及随访体系,落实癌痛患者院外随访制度等,以保障患者持续享有癌痛的规范化管理服务,成为整个行业的标杆。天津医科大学肿瘤医院疼痛治疗科主任王昆教授介绍说,“肿瘤医院借鉴国际先进的癌痛治疗模式,通过推进多学科癌痛规范化治疗,帮助患者科学、有效地消除痛苦,获得最佳的生活质量。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=263374, encodeId=515b2633e43f, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Nov 22 15:53:42 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262904, encodeId=a09826290423, content=镇痛.无痛.解除癌症病人之痛苦., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Mon Nov 20 20:16:33 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262892, encodeId=026b26289296, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Nov 20 18:35:45 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-11-22 三生有幸9135

    学习一下谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=263374, encodeId=515b2633e43f, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Nov 22 15:53:42 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262904, encodeId=a09826290423, content=镇痛.无痛.解除癌症病人之痛苦., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Mon Nov 20 20:16:33 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262892, encodeId=026b26289296, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Nov 20 18:35:45 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-11-20 1e0f8808m18(暂无匿称)

    镇痛.无痛.解除癌症病人之痛苦.

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=263374, encodeId=515b2633e43f, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Wed Nov 22 15:53:42 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262904, encodeId=a09826290423, content=镇痛.无痛.解除癌症病人之痛苦., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Mon Nov 20 20:16:33 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262892, encodeId=026b26289296, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Nov 20 18:35:45 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-11-20 惠映实验室

    学习了.谢谢.

    0